SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia-Reference-Cited by-同舟云学术

SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia

Published:2016-07-22 Issue:8 Volume:63 Page:1007-1016
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clin Infect Dis.

Author:

File Thomas M.,Rewerska Barbara,Vucinić-Mihailović Violeta,Gonong Joven Roque V.,Das Anita F.,Keedy Kara,Taylor David,Sheets Amanda,Fernandes Prabhavathi,Oldach David,Jamieson Brian D.

Funder

Cempra Inc

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/63/8/1007/16788342/ciw490.pdf

Reference31 articles.

1. Mortality among severe community-acquired pneumonia patients depends on combinations of 2007 IDSA/ATS minor criteria

2. Mathers C , Fat DM , Boerma JT . The global burden of disease: 2004 update. Geneva, Switzerland: WHO, 2008.

3. Donowitz GR . Acute pneumonia. In: Mandell GL , Bennett JE , Dolin R . Principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier, 2010.